Clinical Significance of the PI-RADS Score in Men with Prostate Cancer Undergoing Radical Prostatectomy

被引：0
|
作者：
Nwanze, Julum [1 ]
Teramoto, Yuki [2 ]
Wang, Ying [1 ]
Miyamoto, Hiroshi [1 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY USA
[2] Kyoto Univ Hosp, Kyoto, Japan
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
788
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [41] PI-RADS 2.0 for Prostate MRI
    Franiel, T.
    Roethke, M.
    RADIOLOGE, 2017, 57 (08): : 665 - 678
  • [42] Non-malignancy pathologic findings and their clinical significance on targeted prostate biopsy in men with PI-RADS 4 / 5 lesions on prostate MRI
    Chen, Fei
    Meng, Xiaosong
    Chao, Brain
    Rosenkrantz, Andrew B.
    Melamed, Jonathan
    Zhou, Ming
    Taneja, Samir
    Deng, Fang-Ming
    LABORATORY INVESTIGATION, 2018, 98 : 333 - 333
  • [43] EVALUATION OF PI-RADS SCORE ≤3 LESIONS AT MULTIPARAMETRIC MRI. IMPLICATION FOR CLINICAL MANAGEMENT AND PROSTATE CANCER DIAGNOSIS
    Di Trapani, Ettore
    Catellani, Michele
    Russo, Andrea
    Conti, Andrea
    Mistretta, Francesco Alessandro
    Ferro, Matteo
    Bianco, Raffaele
    Cioffi, Antonello
    Musi, Gennaro
    Renne, Giuseppe
    Matei, Deliu Victor
    De Cobelli, Ottavio
    ANTICANCER RESEARCH, 2018, 38 (04) : 2535 - 2535
  • [44] Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI
    Samaratunga, Hemamali
    Hussey, David
    Le Fevre, Ian K.
    Egevad, Lars
    Sarikwal, Anubhav
    Carim, Humza
    Delahunt, Brett
    PATHOLOGY, 2024, 56 (03) : 413 - 415
  • [45] Non-malignancy pathologic findings and their clinical significance on targeted prostate biopsy in men with PI-RADS 4 / 5 lesions on prostate MRI
    Chen, Fei
    Meng, Xiaosong
    Chao, Brain
    Rosenkrantz, Andrew B.
    Melamed, Jonathan
    Zhou, Ming
    Taneja, Samir
    Deng, Fang-Ming
    MODERN PATHOLOGY, 2018, 31 : 333 - 333
  • [46] ROLE OF PI-RADS VERSION 2 FOR PREDICTION OF INCIDENTAL PROSTATE CANCER AFTER RADICAL CYSTOPROSTATECTOMY
    Song, Wan
    Jeong, Jae Yong
    Kim, Tae Heon
    Yoon, Hyun Suk
    Kim, Kwang Hyun
    Yoon, Hana
    Chung, Woo Sik
    Sim, Bong Suk
    Lee, Dong Hyeon
    JOURNAL OF UROLOGY, 2019, 201 (04): : E178 - E179
  • [47] PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance
    Behfar, Ehdaie
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1234 - 1235
  • [48] Evaluation of the PI-RADS Scoring System for Classifying mpMRI Findings in Men with Suspicion of Prostate Cancer
    Junker, Daniel
    Schaefer, Georg
    Edlinger, Michael
    Kremser, Christian
    Bektic, Jasmin
    Horninger, Wolfgang
    Jaschke, Werner
    Aigner, Friedrich
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [49] Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment
    Schelb, Patrick
    Kohl, Simon
    Radtke, Jan Philipp
    Wiesenfarth, Manuel
    Kickingereder, Philipp
    Bickelhaupt, Sebastian
    Kuder, Tristan Anselm
    Stenzinger, Albrecht
    Hohenfellner, Markus
    Schlemmer, Heinz-Peter
    Maier-Hein, Klaus H.
    Bonekamp, David
    RADIOLOGY, 2019, 293 (03) : 607 - 617
  • [50] Clinical-imaging metrics for the diagnosis of prostate cancer in PI-RADS 3 lesions
    Kang, Zhen
    Margolis, Daniel J.
    Tian, Ye
    Li, Qiubai
    Wang, Shaogang
    Wang, Liang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (11) : 371e1 - 371e10
12345